nach oben

International Orthopaedics

Erschienen in:

01.11.2013 | Original Paper

Endothelial nitric oxide synthase gene polymorphisms and the risk of osteonecrosis of the femoral head in systemic lupus erythematosus

verfasst von: Hak Soo Kim, Sang-Cheol Bae, Tae-Ho Kim, Shin-Yoon Kim

Erschienen in: International Orthopaedics | Ausgabe 11/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Nitric oxide (NO), a short-lived gaseous free radical, is a potent mediator of biological responses involved in the pathogenesis of autoimmune rheumatic diseases, such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Nitric oxide also serves as an important signal in physiological processes, including angiogenesis, thrombosis, and bone turnover, which are known to be related to the pathogenesis of osteonecrosis. We investigated whether NOS3 gene polymorphisms are associated with risk of osteonecrosis of the femoral head (ONFH).

Methods

Five polymorphisms in the NOS3 gene were genotyped using TaqMan assays in 306 controls, 150 SLE patients, and 50 SLE patients with ONFH (SLE_ONFH).

Results

We found that Asp258Asp and Glu298Asp (G894T) polymorphisms in the NOS3 gene were significantly associated with risk of ONFH. Additionally, we calculated haplotype frequencies of a linkage disequilibrium (LD) block in NOS3 (rs1799983 − rs1800780) and tested for haplotype associations. The haplotypes G-A and T-A showed significant protective (P = 1.6 × 10^-3; OR 0.39, 95 % confidence intervals (CI) 0.22–0.7) and increased risk (P = 2.0 x 10^-5–6.0 x 10^-4; OR 3.17−3.73) effects for ONFH, respectively.

Conclusions

These results suggest that exonic NOS3 polymorphisms may increase the risk of ONFH in Korean SLE patients

Nur mit Berechtigung zugänglich

Assouline-Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME (2002) Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum 32:94–124PubMed

Wang GJ, Cui Q, Balian G (2000) The Nicolas Andry award. The pathogenesis and prevention of steroid-induced osteonecrosis. Clin Orthop Relat Res 370:295–310PubMedCrossRef

Abu-Shakra M, Buskila D, Shoenfeld Y (2003) Osteonecrosis in patients with SLE. Clin Rev Allergy Immunol 25:13–24PubMedCrossRef

Jones LC, Hungerford DS (2007) The pathogenesis of osteonecrosis. Instr Course Lect 56:179–196PubMed

Mankin HJ (1992) Nontraumatic necrosis of bone (osteonecrosis). N Engl J Med 326:1473–1479PubMedCrossRef

Ferrari P, Schroeder V, Anderson S, Kocovic L, Vogt B, Schiesser D, Marti HP, Ganz R, Frey FJ, Kohler HP (2002) Association of plasminogen activator inhibitor-1 genotype with avascular osteonecrosis in steroid-treated renal allograft recipients. Transplantation 74:1147–1152PubMedCrossRef

Kim SY, Suh JS, Park EK, Jung WB, Kim JW, Koo KH, Kim CY (2003) Factor V Leiden gene mutation in femoral head osteonecrosis. J Korean Ortho Res Soc 6:259–264

Chang JD, Hur M, Lee SS, Yoo JH, Lee KM (2008) Genetic background of nontraumatic osteonecrosis of the femoral head in the Korean population. Clin Orthop Relat Res 466:1041–1046PubMedCrossRef

Koo KH, Lee JS, Lee YJ, Kim KJ, Yoo JJ, Kim HJ (2006) Endothelial nitric oxide synthase gene polymorphisms in patients with nontraumatic femoral head osteonecrosis. J Orthop Res 24:1722–1728PubMedCrossRef

10.

Cooke JP, Dzau VJ (1997) Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med 48:489–509PubMedCrossRef

11.

Belmont HM, Levartovsky D, Goel A, Amin A, Giorno R, Rediske J, Skovron ML, Abramson SB (1997) Increased nitric oxide production accompanied by the up-regulation of inducible nitric oxide synthase in vascular endothelium from patients with systemic lupus erythematosus. Arthritis Rheum 40:1810–1816PubMedCrossRef

12.

Aguirre J, Buttery L, O'Shaughnessy M, Afzal F, Fernandez de Marticorena I, Hukkanen M, Huang P, MacIntyre I, Polak J (2001) Endothelial nitric oxide synthase gene-deficient mice demonstrate marked retardation in postnatal bone formation, reduced bone volume, and defects in osteoblast maturation and activity. Am J Pathol 158:247–257PubMedCrossRef

13.

Glueck CJ, Freiberg RA, Oghene J, Fontaine RN, Wang P (2007) Association between the T-786C eNOS polymorphism and idiopathic osteonecrosis of the head of the femur. J Bone Joint Surg Am 89:2460–2468PubMedCrossRef

14.

Gagala J, Buraczynska M, Mazurkiewicz T, Ksiazek A (2013) Endothelial nitric oxide synthase gene intron 4 polymorphism in non-traumatic osteonecrosis of the femoral head. Int Orthop. doi:10.1007/s00264-013-1892-7

15.

Lee HJ, Choi SJ, Hong JM, Lee WK, Baek JI, Kim SY, Park EK, Kim SY, Kim TH, Kim UK (2009) Association of a polymorphism in the intron 7 of the SREBF1 gene with osteonecrosis of the femoral head in Koreans. Ann Hum Genet 73:34–41PubMedCrossRef

16.

Hedrick PW (1987) Gametic disequilibrium measures: proceed with caution. Genetics 117:331–341PubMed

17.

Jones LC, Mont MA, Le TB, Petri M, Hungerford DS, Wang P, Glueck CJ (2003) Procoagulants and osteonecrosis. J Rheumatol 30:783–791PubMed

18.

Kerachian MA, Harvey EJ, Cournoyer D, Chow TY, Séguin C (2006) Avascular necrosis of the femoral head: vascular hypotheses. Endothelium 13:237–244PubMedCrossRef

19.

Bjorkman A, Svensson PJ, Hillarp A, Burtscher IM, Runow A, Benoni G (2004) Factor V Leiden and prothrombin gene mutation: risk factors for osteonecrosis of the femoral head in adults. Clin Orthop Relat Res 425:168–172PubMedCrossRef

20.

Glueck CJ, Freiberg RA, Fontaine RN, Tracy T, Wang P (2001) Hypofibrinolysis, thrombophilia, osteonecrosis. Clin Orthop Relat Res 386:19–33PubMedCrossRef

21.

Samuels A, Perry MJ, Gibson RL, Colley S, Tobias JH (2001) Role of endothelial nitric oxide synthase in estrogen-induced osteogenesis. Bone 29:24–29PubMedCrossRef

22.

Lagumdzija A, Ou G, Petersson M, Bucht E, Gonon A, Pernow Y (2004) Inhibited anabolic effect of insulin-like growth factor-I on stromal bone marrow cells in endothelial nitric oxide synthase-knockout mice. Acta Physiol Scand 182:29–35PubMedCrossRef

23.

Clancy RM, Amin AR, Abramson SB (1998) The role of nitric oxide in inflammation and immunity. Arthritis Rheum 41:1141–1151PubMedCrossRef

24.

Tsukada T, Yokoyama K, Arai T, Takemoto F, Hara S, Yamada A, Kawaguchi Y, Hosoya T, Igari J (1998) Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophys Res Commun 245:190–193PubMedCrossRef

25.

Nakayama M, Yasue H, Yoshimura M, Shimasaki Y, Kugiyama K, Ogawa H, Motoyama T, Saito Y, Ogawa Y, Miyamoto Y, Nakao K (1999) T-786– > C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 99:2864–2870PubMedCrossRef

26.

Kim IJ, Bae J, Lim SW, Cha DH, Cho HJ, Kim S, Yang DH, Hwang SG, Oh D, Kim NK (2007) Influence of endothelial nitric oxide synthase gene polymorphisms (−786T > C, 4a4b, 894G > T) in Korean patients with coronary artery disease. Thromb Res 119:579–585PubMedCrossRef

Titel: Endothelial nitric oxide synthase gene polymorphisms and the risk of osteonecrosis of the femoral head in systemic lupus erythematosus
verfasst von: Hak Soo Kim
Sang-Cheol Bae
Tae-Ho Kim
Shin-Yoon Kim
Publikationsdatum: 01.11.2013
Verlag: Springer Berlin Heidelberg
Erschienen in: International Orthopaedics / Ausgabe 11/2013
Print ISSN: 0341-2695
Elektronische ISSN: 1432-5195
DOI: https://doi.org/10.1007/s00264-013-1966-6

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen.
» Jetzt entdecken

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2013

Influence of cryopreservation, cultivation time and patient’s age on gene expression in Hyalograft® C cartilage transplants

Biomechanical evaluation of augmented and nonaugmented primary repair of the anterior cruciate ligament: an in vivo animal study

Comparative clinical study on deformity correction accuracy of different external fixators

A randomised prospective evaluation of ceramic-on-ceramic and ceramic-on-highly cross-linked polyethylene bearings in the same patients with primary cementless total hip arthroplasty

Microfractures at the rotator cuff footprint: a randomised controlled study

Neglected patellar tendon ruptures—a simple modified reconstruction using hamstrings tendon graft